CKD-MBD in Brazil: the gap between reality and the recommended guidelines
- PMID: 29796588
- PMCID: PMC6533963
- DOI: 10.1590/1678-4685-JBN-201800010003
CKD-MBD in Brazil: the gap between reality and the recommended guidelines
Similar articles
-
Chronic kidney disease: KDIGO CKD-MBD guideline update: evolution in the face of uncertainty.Nat Rev Nephrol. 2017 Oct;13(10):600-602. doi: 10.1038/nrneph.2017.118. Epub 2017 Aug 21. Nat Rev Nephrol. 2017. PMID: 28824172 No abstract available.
-
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).Intern Med. 2008;47(11):989-94. doi: 10.2169/internalmedicine.47.1051. Epub 2008 Jun 2. Intern Med. 2008. PMID: 18520108 Review.
-
[Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].Clin Calcium. 2012 Jul;22(7):979-86. Clin Calcium. 2012. PMID: 22750929 Review. Japanese.
-
Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD.BMC Nephrol. 2018 Sep 20;19(1):240. doi: 10.1186/s12882-018-1037-8. BMC Nephrol. 2018. PMID: 30236082 Free PMC article. Review.
-
[Kidney and bone update : the 5-year history and future of CKD-MBD. The changes after the introduction of CKD-MBD as a new entity].Clin Calcium. 2012 Jul;22(7):969-77. Clin Calcium. 2012. PMID: 22750928 Review. Japanese.
Cited by
-
Secondary hyperparathyroidism due to chronic kidney disease and access to clinical treatment and parathyroidectomy in Brazil: a nationwide survey.J Bras Nefrol. 2025 Apr-Jun;47(2):e20240158. doi: 10.1590/2175-8239-JBN-2024-0158en. J Bras Nefrol. 2025. PMID: 39998901 Free PMC article.
-
Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.J Bras Nefrol. 2020 Jan 20;42(2):138-146. doi: 10.1590/2175-8239-JBN-2019-0045. J Bras Nefrol. 2020. PMID: 32756862 Free PMC article.
-
Overview of renal osteodystrophy in Brazil: a cross-sectional study.J Bras Nefrol. 2023 Apr-Jun;45(2):257-261. doi: 10.1590/2175-8239-JBN-2022-0146en. J Bras Nefrol. 2023. PMID: 37158484 Free PMC article.
References
-
- Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Kidney Disease: Improving Global Outcomes (KDIGO) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease improving global outcomes (KDIGO) Kidney Int. 2006;69:1945–1953. - PubMed
-
- Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis. 2008;52:519–530. - PubMed
-
- Fujii H, Joki N. Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol. 2017;21:S53–S63. - PubMed
-
- Gentry J, Webb J, Davenport D, Malluche HH. Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy. Clin Nephrol. 2016;86:9–17. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous